COMPASS Pathways (CMPS)

Overall impact
A (89)

Commentary

COMPASS Pathways is a leader for overall positive impact. With an 'A' rating of 89.1 for overall impact (98th percentile compared to all companies), COMPASS Pathways ranks 1st out of 71 industry peers, ahead of ModivCare, Ontrak, Hanger and 67 others. On top material causes for COMPASS Pathways's industry (Healthcare Providers), COMPASS Pathways performs well in Child and Maternal Health (95.3 score), No Violence Against Women (90.2), Improved Mental Health (95.8) and 15 other causes where it received an 'A' score and performs poorly in Humane Treatment of Animals (18.9 score).
Company
Founded
2016
Employees
186
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
United Kingdom
Share classes
CMPS
COMPASS Pathways
Description
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Material causes
Ethos considers the following causes material for COMPASS Pathways, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.